INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 47m ago
HOUSE PTR6m ago
SEC 13F6m ago
ROBINHOOD CHAIN6m ago
SEC FORM 4/Grant or awardVerified data

Nilsson Stefan reported NVST

President, Nobel Biocare · Envista Holdings Corp · Envista Holdings Corp — Employee Stock Option (Right to Buy)

Side
A
Value
—
Shares
18.0K
Price
—
Executed
Feb 25, 2026
Disclosed
Feb 27, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Feb 25 executedFeb 27, 2026 disclosed

NVST · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
9/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · NVST

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    16
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$212K
    7,710 sh
    		Aug 25, 2026Aug 27, 2026
    traded Aug 25, 2026
    		+2dSEC FORM 4

    Evidence

    16
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$141K
    5,147 sh
    		Aug 25, 2026Aug 27, 2026
    traded Aug 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    NS
    Nilsson StefanPresident, Nobel Biocare
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$22K
    804 sh
    		Aug 25, 2026Aug 27, 2026
    traded Aug 25, 2026
    		+2dSEC FORM 4

    Evidence

    16
    RM
    Reis MischaSVP, Strategy & Bus. Dev.
    NVSTEnvista Holdings Corp
    Open-market sale · 10b5-1 plan
    		SELL$220K
    8,000 sh
    		Aug 20, 2026Aug 24, 2026
    traded Aug 20, 2026
    		+4dSEC FORM 4

    Evidence

    9
    NS
    Nilsson StefanPresident, Nobel Biocare
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$5,385
    182 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    13
    NS
    Nilsson StefanPresident, Nobel Biocare
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    7,605 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    NS
    Nilsson StefanPresident, Nobel Biocare
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    13.8K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    16
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$64K
    2,177 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    13
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    7,605 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    13.8K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    18.0K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    16
    KC
    Kaabi Faez CChief Accounting Officer
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$147K
    4,964 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    17
    KC
    Kaabi Faez CChief Accounting Officer
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    13.5K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Tax withholding
    		F$42K
    1,412 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    13.8K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    13
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    7,605 sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Grant or award
    		A—
    18.0K sh
    		Feb 25, 2026Feb 27, 2026
    traded Feb 25, 2026
    		+2dSEC FORM 4

    Evidence

    17
    KC
    Kaabi Faez CChief Accounting Officer
    NVSTEnvista Holdings Corp
    Grant or award
    		A$28K
    1,186 sh
    		Feb 1, 2026Feb 3, 2026
    traded Feb 1, 2026
    		+2dSEC FORM 4

    Evidence

    9
    AV
    Acurio VeronicaPresident, Orthodontics
    NVSTEnvista Holdings Corp
    Grant or award
    		A$23K
    998 sh
    		Feb 1, 2026Feb 3, 2026
    traded Feb 1, 2026
    		+2dSEC FORM 4

    Evidence

    21
    BR
    Befidi RobertPresident, Diagnostics
    NVSTEnvista Holdings Corp
    Grant or award
    		A$23K
    998 sh
    		Feb 1, 2026Feb 3, 2026
    traded Feb 1, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002045818-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Feb 25, 2026
    Published
    Feb 27, 2026
    Ingested by INSIDER
    Nov 5, 04:14 UTC
    Last re-read
    Nov 5, 04:14 UTC

    Extracted facts

    Filer
    Nilsson Stefan
    Role
    President, Nobel Biocare
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Envista Holdings Corp — Employee Stock Option (Right to Buy)
    Ticker
    NVST
    Shares
    18.0K
    Price per share
    $0
    Execution date (reported)
    Feb 25, 2026
    Owned after transaction
    18.0K shares
    Days from execution to publication
    2

    What this establishes

    Nilsson Stefan filed this Form 4 reporting a grant or award of NVST on Feb 25, 2026. It became public on Feb 27, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    President, Nobel Biocare
    Nilsson Stefancik:0002045818
    Issuer
    Envista Holdings Corpcik:0001757073

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.